{"id":6937,"date":"2026-01-15T10:50:21","date_gmt":"2026-01-15T09:50:21","guid":{"rendered":"https:\/\/carlroth.blog\/nobel-prize-in-physiology-or-medicine-2025\/"},"modified":"2026-03-04T10:59:42","modified_gmt":"2026-03-04T09:59:42","slug":"nobel-prize-in-physiology-or-medicine-2025","status":"publish","type":"post","link":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/","title":{"rendered":"Nobel Prize in Physiology or Medicine 2025"},"content":{"rendered":"\n

Immune tolerance or the immune system\u2019s brake pedal <\/h2>\n\n

Our body\u2019s immune system is vital to our survival. Given the enormous breadth of germs that have the potential to make us ill, which surround us every day \u2013 not just in winter \u2013 severe infections are strictly speaking rare. Our (fully functioning) immune system acts as an efficient \u201chealth police force\u201d protecting us from pathogenic microorganisms and even abnormal (cancerous) cells. It is a complex interplay of different immune cells from our innate and adaptive immune system that affords us this protection. They detect and eliminate foreign and abnormal cells and they also build up an antibody-based immune protection. <\/p>\n\n

Nevertheless, as efficient and vital to survival as this cellular health police force may be, moderation \u2013 as with so many things in life \u2013 is key. Every immune system has to be kept in balance at all costs. It must reliably be able to distinguish between friend and foe, that\u2019s to say between the body\u2019s own cells and foreign cells, and to quickly downregulate after successful deployment. Problems arise when this is not the case, because an off-balance immune system is a serious threat to our body: dangerous overreactions of the immune system can even send the body into life-threatening shock, in autoimmune diseases, immune cells attack and destroy the body\u2019s own structures. The difficult yet essential task of keeping our body\u2019s defences in check lies with another cellular guardian, as discovered and characterised by Shimon Sakaguchi, Mary E. Brunkow and Fred Ramsdell<\/strong>, earning them the Nobel Prize in Physiology or Medicine<\/strong> in late 2025. What did they do? <\/p>\n\n

\"\"<\/figure>\n\n

In 1995 Sakaguchi <\/strong>discovered a new class of immune cells, known as regulatory T cells \u2013 Treg<\/strong> or Treg<\/sub><\/strong> for short. Strictly speaking, scientists were already aware of these cells in the 1970s \u2013 albeit under the name \u201csuppressor cells\u201d back then. However, methods at that time could not reliably distinguish these from other T cells. And this is precisely what Sakaguchi ultimately achieved through his pioneering work. The answer lay in sophisticated analytics and a special surface marker developed only by the Tregs within the large group of T-lymphocytes. This marker, called CD25, identifies the alpha chain of the Interleukin-2 receptor. <\/p>\n\n

\"\"<\/figure>\n\n

It became apparent that the Tregs act as \u201cimmune system security guards\u201d, preventing the body\u2019s defence system from attacking its own organism. As such, they have an immunoregulatory function. This gives rise to a state that researchers call immune tolerance<\/strong>. Until this was discovered by Sakaguchi, the prevailing scientific opinion was that immune tolerance was primarily regulated centrally in the thymus<\/strong>. T lymphocytes are produced in the bone marrow and mature in the thymus, where they are programmed for their subsequent tasks. Immune cells that mistakenly target the body\u2019s own structures are thereby \u201cweeded out\u201d, i.e. they are driven to programmed suicide, in a process called apoptosis. But every system is fallible. Sakaguchi discovered the regulatory T cells had the additional control capability required to suppress overactive immune responses or those that turn against the body\u2019s own structures. And all this happens right at the heart of proceedings \u2013 in our blood, in the lymphatic system and in the tissue. <\/p>\n\n

\"\"<\/figure>\n\n

Meanwhile, in 2001 Mary E. Brunkow<\/strong> and Fred Ramsdell<\/strong> happened upon the genetic basis of a severe autoimmune disease: immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX syndrome).<\/strong> The scientists identified the cause to be a mutation of the FOXP3 <\/strong>gene, which can also be found in so-called scurfy mice with autoimmune disease. <\/p>\n\n

Two years later, Ramsdell and Sakaguchi<\/strong> successfully linked these two discoveries together, by proving that the FOXP3 protein controls the development of regulatory T cells, acting as a transcription factor, or to a certain extent as an \u201con-\/off switch\u201d. This established the connection between regulatory T cells, autoimmune diseases and FOXP3<\/strong> and the concept of peripheral immune tolerance<\/strong> was born. <\/p>\n\n

\u201cWe now have a better understanding of how the immune system works and why we don\u2019t all develop a severe autoimmune disease,\u201d reasons the Nobel committee upon announcing their decision to the prize winners.<\/p>\n\n

But how exactly do the Tregs manage to put the brakes on our immune system without weakening its overall powers of defence? And how can these fundamental findings by this year\u2019s Nobel prize winners be expanded and utilised? <\/p>\n\n

How do regulatory T cells regulate the immune system \u2013 and who or what is regulating them?<\/h3>\n\n

One way they do this is by slowing down the division activities of T helper cells while at the same time restricting their production of immune messengers, by blocking key transcription factors in the helper cells. In this way, Tregs suppress inflammatory processes and actively contribute to tissue regeneration by releasing cytokines. <\/p>\n\n

\"\"<\/figure>\n\n
<\/div>\n\n
\"\"<\/figure>\n\n
<\/div>\n\n

T helper cells are activated by means of antigen binding (e.g. virus surface proteins) and then release cytokines. These messengers activate immune cells (e.g., B cells and cytotoxic T cells) and, in turn, a specific immune response to pathogens and cancer cells. T helper cells are an important element of adaptive immunity and serve as key players in the body\u2019s fight against infections, autoimmune diseases, allergies and cancer. <\/p>\n\n

However, if these immune system brakes<\/strong> were applied permanently, our defences would be weakened. It is precisely this effect that is exploited by abnormal cells in tumours, by gathering regulatory T cells around themselves and, in doing so, limiting the body\u2019s healing immune response to the tumour. Therefore, the regulators must themselves be regulated. <\/p>\n\n

The Tregs are activated<\/strong> on an antigen-specific basis and the cells multiply faster than normal T cells, quickly triggering a high level of activity. They are deactivated <\/strong>promptly and automatically: Tregs are extremely unstable, meaning they die comparatively quickly through apoptosis. <\/p>\n\n

Enormous potential for application albeit with some obstacles<\/h3>\n\n

Not only does the work of the three Nobel prize winners provide fundamental basic knowledge, but the Tregs themselves also present enormous therapeutic potential<\/strong>. As an \u201cactive ingredient\u201d for the treatment of conditions associated with an overactive or misguided immune system, Tregs could help us to better control autoimmune diseases, allergies or even rejection responses following organ transplants. If, by contrast, we weaken the effect of the Tregs \u2013 severing the \u201cimmunity brakes\u201d so to speak \u2013 this could be beneficial to cancer treatment. CAR T cell therapy, which has emerged in the past few years, could also benefit from Tregs if this new form of treatment were expanded to diseases with an overactive immune system, such as certain types of hepatitis or neurodegenerative diseases, type 1 diabetes or multiple sclerosis. <\/p>\n\n

However, long after their discovery, Tregs are still limited by one general issue when it comes to exploiting their therapeutic potential<\/strong>. The very characteristic that is vital to preventing Tregs from permanently weakening the body\u2019s immune system also presents a huge obstacle for further research, optimisation and clinical application: namely, their instability. Not only does this present a challenge when it comes to extracting, purifying and expanding the cells in sufficient quantities for therapeutic purposes, but the Tregs also have a tendency to revert to \u201cnormal\u201d T cells in laboratory conditions. Countless clinical studies on Treg-based therapies, such as for type 1 diabetes, Lupus erithematodes, rheumatoid arthritis or Hashimoto’s thyroiditis, have already been outlined, but as yet none has got beyond clinical phases I or II. <\/p>\n\n

That could conceivably change: of all the study groups working on the subject, it is the group led by freshly decorated Nobel prize winner Sakaguchi that has now published two scientific papers, in which researchers describe the protocols for the stable production of Tregs from mice and humans [1] as well as their application for the autoimmune disease pemphigus vulgaris. Sakaguchi and his team also developed a protocol for the pharmacological epigenetic reprogramming of T cells and used this to transform conventional (stable) CD4+ T helper cells into (also stable) Tregs. It is hoped that these approaches can be established for a broader field of application. Then, Tregs could to some extent (boosted along by the Nobel prize) finally climb into the realms of clinical application and realise its full potential. Goodness knows they deserve it. <\/p>\n\n

<\/div>\n\n
\n\n
<\/div>\n\n

Cited sources:<\/strong><\/p>\n\n

[1] N. Mikami et al., 2025, Science Translational Medicine DOI: 10.1126\/scitranslmed.adr6049<\/a><\/p>\n\n

[2] M. Mukai et al., 2025, Science Translational Medicine DOI: 10.1126\/scitranslmed.adq9913<\/a><\/p>\n\n

Other sources:<\/strong><\/p>\n\n

Pressemitteilung: Nobelpreis f\u00fcr Physiologie oder Medizin 2025 – NobelPrize.org<\/a><\/p>\n\n

Scientific background to the Nobel Prize in Physiology or Medicine 2025<\/a><\/p>\n\n

Ausgabe_A<\/a><\/p>\n\n

Immuntoleranz im Fokus: Medizin-Nobelpreis 2025<\/a><\/p>\n\n

Medizin-Nobelpreis 2025 f\u00fcr Erforschung der Immunregulation – Spektrum der Wissenschaft<\/a><\/p>\n\n

Medizin-Nobelpreis 2025 f\u00fcr Forschung zur Immuntoleranz<\/a><\/p>\n\n

Wie regulatorische T-Zellen das Immunsystem kontrollieren<\/a><\/p>\n\n

Potente Sensibelchen in der Klinik | PZ \u2013 Pharmazeutische Zeitung<\/a><\/p>\n\n

239 Regulatorische T-Zellen (Treg) als Basismarker zum Monitoring immunmodulierender Ma\u00dfnahmen<\/a><\/p>\n\n

Selbstkontrolle des Immunsystems d\u00e4mpft Krebsabwehr – Deutsches Krebsforschungszentrum<\/a><\/p>\n\n

Wie regulatorische T-Zellen reguliert werden – MT-Dialog<\/a><\/p>\n\n

Clinical studies:<\/strong><\/p>\n\n

Medizinische Hochschule Hannover : Bio-Navi gegen fehlgeleitetes Immunsystem<\/a><\/p>\n\n

Fehlgeleitete Immunreaktionen: Regulatorische CAR-T-Zellen entwickelt – Biermann Medizin<\/a><\/p>\n\n

DRKS – Deutsches Register Klinischer StudienECCO 2025: Phase-I-Studiendaten zum autologen Treg-Zell-Transfer bei refrakt\u00e4rer Colitis ulcerosa | congress-x-press<\/a><\/p>\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":6834,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[659],"tags":[905,904,756,903],"class_list":["post-6937","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-roth-xplains","tag-immune-system","tag-immune-tolerance","tag-nobelpreis-en","tag-physiology-medicine"],"yoast_head":"\nNobel Prize in Physiology or Medicine 2025 - Carl ROTH<\/title>\n<meta name=\"description\" content=\"Regulatory T cells, Treg, Treg, peripheral immune tolerance, immune system autoimmune diseases, allergies \u2013 why the Nobel-prize-winning discovery of regulatory T cells is long-awaited and groundbreaking and what we can expect from the \u201cimmune system\u2019s security guards\u201d in future. Let\u2019s take a closer look.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nobel Prize in Physiology or Medicine 2025 - Carl ROTH\" \/>\n<meta property=\"og:description\" content=\"Regulatory T cells, Treg, Treg, peripheral immune tolerance, immune system autoimmune diseases, allergies \u2013 why the Nobel-prize-winning discovery of regulatory T cells is long-awaited and groundbreaking and what we can expect from the \u201cimmune system\u2019s security guards\u201d in future. Let\u2019s take a closer look.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Carl ROTH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Carl-Roth-GmbH-Co-KG-1726237960736129\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-15T09:50:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-04T09:59:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carlroth.blog\/wp-content\/uploads\/2026\/01\/Nobelpreis-Physiologie-Medizin-2025-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"670\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carl Roth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@carlrothgmbh\" \/>\n<meta name=\"twitter:site\" content=\"@carlrothgmbh\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carl Roth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/\"},\"author\":{\"name\":\"Carl Roth\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#\\\/schema\\\/person\\\/25db7e77cfa95d3329269a1696d5dcc9\"},\"headline\":\"Nobel Prize in Physiology or Medicine 2025\",\"datePublished\":\"2026-01-15T09:50:21+00:00\",\"dateModified\":\"2026-03-04T09:59:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/\"},\"wordCount\":1494,\"publisher\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/carlroth.blog\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Nobelpreis-Physiologie-Medizin-2025-1.jpg\",\"keywords\":[\"Immune system\",\"Immune tolerance\",\"Nobelpreis\",\"Physiology\\\/Medicine\"],\"articleSection\":[\"ROTH Xplains\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/\",\"url\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/\",\"name\":\"Nobel Prize in Physiology or Medicine 2025 - Carl ROTH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/carlroth.blog\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Nobelpreis-Physiologie-Medizin-2025-1.jpg\",\"datePublished\":\"2026-01-15T09:50:21+00:00\",\"dateModified\":\"2026-03-04T09:59:42+00:00\",\"description\":\"Regulatory T cells, Treg, Treg, peripheral immune tolerance, immune system autoimmune diseases, allergies \u2013 why the Nobel-prize-winning discovery of regulatory T cells is long-awaited and groundbreaking and what we can expect from the \u201cimmune system\u2019s security guards\u201d in future. Let\u2019s take a closer look.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/carlroth.blog\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Nobelpreis-Physiologie-Medizin-2025-1.jpg\",\"contentUrl\":\"https:\\\/\\\/carlroth.blog\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Nobelpreis-Physiologie-Medizin-2025-1.jpg\",\"width\":670,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/nobel-prize-in-physiology-or-medicine-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nobel Prize in Physiology or Medicine 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/\",\"name\":\"Carl ROTH\",\"description\":\"Neues aus Labor, Life Science und Chemie.\",\"publisher\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#organization\",\"name\":\"Carl Roth GmbH + Co. KG\",\"url\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/carlroth.blog\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/Logo-Carl-Roth-94px.png\",\"contentUrl\":\"https:\\\/\\\/carlroth.blog\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/Logo-Carl-Roth-94px.png\",\"width\":111,\"height\":93,\"caption\":\"Carl Roth GmbH + Co. KG\"},\"image\":{\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Carl-Roth-GmbH-Co-KG-1726237960736129\\\/\",\"https:\\\/\\\/x.com\\\/carlrothgmbh\",\"https:\\\/\\\/www.instagram.com\\\/carlrothgmbh\\\/\",\"https:\\\/\\\/www.pinterest.de\\\/carlrothgmbh\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCDMTLx8USBrm_XvWcXaq5Ug\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/carlroth.blog\\\/en\\\/#\\\/schema\\\/person\\\/25db7e77cfa95d3329269a1696d5dcc9\",\"name\":\"Carl Roth\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nobel Prize in Physiology or Medicine 2025 - Carl ROTH","description":"Regulatory T cells, Treg, Treg, peripheral immune tolerance, immune system autoimmune diseases, allergies \u2013 why the Nobel-prize-winning discovery of regulatory T cells is long-awaited and groundbreaking and what we can expect from the \u201cimmune system\u2019s security guards\u201d in future. Let\u2019s take a closer look.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/","og_locale":"en_US","og_type":"article","og_title":"Nobel Prize in Physiology or Medicine 2025 - Carl ROTH","og_description":"Regulatory T cells, Treg, Treg, peripheral immune tolerance, immune system autoimmune diseases, allergies \u2013 why the Nobel-prize-winning discovery of regulatory T cells is long-awaited and groundbreaking and what we can expect from the \u201cimmune system\u2019s security guards\u201d in future. Let\u2019s take a closer look.","og_url":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/","og_site_name":"Carl ROTH","article_publisher":"https:\/\/www.facebook.com\/Carl-Roth-GmbH-Co-KG-1726237960736129\/","article_published_time":"2026-01-15T09:50:21+00:00","article_modified_time":"2026-03-04T09:59:42+00:00","og_image":[{"width":670,"height":400,"url":"https:\/\/carlroth.blog\/wp-content\/uploads\/2026\/01\/Nobelpreis-Physiologie-Medizin-2025-1.jpg","type":"image\/jpeg"}],"author":"Carl Roth","twitter_card":"summary_large_image","twitter_creator":"@carlrothgmbh","twitter_site":"@carlrothgmbh","twitter_misc":{"Written by":"Carl Roth","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#article","isPartOf":{"@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/"},"author":{"name":"Carl Roth","@id":"https:\/\/carlroth.blog\/en\/#\/schema\/person\/25db7e77cfa95d3329269a1696d5dcc9"},"headline":"Nobel Prize in Physiology or Medicine 2025","datePublished":"2026-01-15T09:50:21+00:00","dateModified":"2026-03-04T09:59:42+00:00","mainEntityOfPage":{"@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/"},"wordCount":1494,"publisher":{"@id":"https:\/\/carlroth.blog\/en\/#organization"},"image":{"@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/carlroth.blog\/wp-content\/uploads\/2026\/01\/Nobelpreis-Physiologie-Medizin-2025-1.jpg","keywords":["Immune system","Immune tolerance","Nobelpreis","Physiology\/Medicine"],"articleSection":["ROTH Xplains"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/","url":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/","name":"Nobel Prize in Physiology or Medicine 2025 - Carl ROTH","isPartOf":{"@id":"https:\/\/carlroth.blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#primaryimage"},"image":{"@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/carlroth.blog\/wp-content\/uploads\/2026\/01\/Nobelpreis-Physiologie-Medizin-2025-1.jpg","datePublished":"2026-01-15T09:50:21+00:00","dateModified":"2026-03-04T09:59:42+00:00","description":"Regulatory T cells, Treg, Treg, peripheral immune tolerance, immune system autoimmune diseases, allergies \u2013 why the Nobel-prize-winning discovery of regulatory T cells is long-awaited and groundbreaking and what we can expect from the \u201cimmune system\u2019s security guards\u201d in future. Let\u2019s take a closer look.","breadcrumb":{"@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#primaryimage","url":"https:\/\/carlroth.blog\/wp-content\/uploads\/2026\/01\/Nobelpreis-Physiologie-Medizin-2025-1.jpg","contentUrl":"https:\/\/carlroth.blog\/wp-content\/uploads\/2026\/01\/Nobelpreis-Physiologie-Medizin-2025-1.jpg","width":670,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/carlroth.blog\/en\/nobel-prize-in-physiology-or-medicine-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/carlroth.blog\/en\/"},{"@type":"ListItem","position":2,"name":"Nobel Prize in Physiology or Medicine 2025"}]},{"@type":"WebSite","@id":"https:\/\/carlroth.blog\/en\/#website","url":"https:\/\/carlroth.blog\/en\/","name":"Carl ROTH","description":"Neues aus Labor, Life Science und Chemie.","publisher":{"@id":"https:\/\/carlroth.blog\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carlroth.blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/carlroth.blog\/en\/#organization","name":"Carl Roth GmbH + Co. KG","url":"https:\/\/carlroth.blog\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/carlroth.blog\/en\/#\/schema\/logo\/image\/","url":"https:\/\/carlroth.blog\/wp-content\/uploads\/2017\/04\/Logo-Carl-Roth-94px.png","contentUrl":"https:\/\/carlroth.blog\/wp-content\/uploads\/2017\/04\/Logo-Carl-Roth-94px.png","width":111,"height":93,"caption":"Carl Roth GmbH + Co. KG"},"image":{"@id":"https:\/\/carlroth.blog\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Carl-Roth-GmbH-Co-KG-1726237960736129\/","https:\/\/x.com\/carlrothgmbh","https:\/\/www.instagram.com\/carlrothgmbh\/","https:\/\/www.pinterest.de\/carlrothgmbh\/","https:\/\/www.youtube.com\/channel\/UCDMTLx8USBrm_XvWcXaq5Ug"]},{"@type":"Person","@id":"https:\/\/carlroth.blog\/en\/#\/schema\/person\/25db7e77cfa95d3329269a1696d5dcc9","name":"Carl Roth"}]}},"_links":{"self":[{"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/posts\/6937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/comments?post=6937"}],"version-history":[{"count":1,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/posts\/6937\/revisions"}],"predecessor-version":[{"id":6938,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/posts\/6937\/revisions\/6938"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/media\/6834"}],"wp:attachment":[{"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/media?parent=6937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/categories?post=6937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carlroth.blog\/en\/wp-json\/wp\/v2\/tags?post=6937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}